Results 51 to 60 of about 31,215 (290)

Potentially inappropriate medication in older participants of the Berlin Aging Study II (BASE-II) - Sex differences and associations with morbidity and medication use [PDF]

, 2019
INTRODUCTION: Multimorbidity in advanced age and the need for drug treatment may lead to polypharmacy, while pharmacokinetic and pharmacodynamic changes may increase the risk of adverse drug events (ADEs).
A Calderon-Larranaga, A Meyer, A Renom-Guiteras, B Pesch, By the American Geriatrics Society Beers Criteria Update Expert P, C Coupland, C. Walker, CE Leonard, CH Vinkers, D Gerstorf, D O'Mahony, DM Fick, DM Nathan, E Sonnerstam, E Tommelein, Elisabeth Steinhagen-Thiessen, FR Motter, GE Miller, Gianluigi Forloni, HG Endres, I Schubert, Ilja Demuth, Juliane Bolbrinker, K Hedna, K Heser, KU Saum, L Bertram, M Abu Sin, M Butler, M König, M König, M Molokhia, Maximilian König, ME Charlson, MH Beers, ML Laroche, MM Wolfe, MP Oktora, N Kachru, N Masnoon, O Abraham, O Reich, P Gallagher, P Gallo, P Martinot, PH Novaes, PJ McLeod, R Linder, Reinhold Kreutz, RT Chlebowski, RU Kristensen, S Holt, S Trelle, Sarah Toepfer, SK Nothelle, SM Wallerstedt, ST DeKosky, U Schwabe   +57 more
core   +1 more source

Cardiorenal Outcomes of Dapagliflozin vs. Empagliflozin in Advanced Chronic Kidney Disease and Diabetes

Clinical Pharmacology &Therapeutics, EarlyView.
Target trial emulation of a multi‐institutional electronic health record network showed comparable cardiorenal effectiveness and safety of dapagliflozin versus empagliflozin in adults with type 2 diabetes and advanced‐stage chronic kidney disease.
Shih‐Hsuan Lin, Jia‐Jin Chen, Ching‐Chung Hsiao, Yu‐Wei Fang, Meng‐Ting Chen, Ming‐Hsien Tsai, Huang‐Yu Yang   +6 more
wiley   +1 more source

The place of gliclazide MB in modern treatment strategies for patients with type 2 diabetes mellitus

Сахарный диабет
Sulfonylurea (SU) are an effective class of oral hypoglycemic drugs that have been used in clinical practice for more than 70 years. Despite the common mechanism of action, members of the class have significant intraclass differences in hypoglycemic ...
N. A. Petunina, N. S. Martirosian, E. V. Goncharova, M. E. Telnova, I. A. Kuzina, A. O. Shchetinina, E. A. Elmurzaeva   +6 more
doaj   +1 more source

Seletividade do nicosulfuron em três estádios fenológicos de milho-pipoca Selectivity of nicosulfuron at three popcorn growth stages

Planta Daninha, 2012
Objetivou-se com este trabalho avaliar a seletividade do herbicida nicosulfuron em três estádios fenológicos de milho-pipoca (híbrido White A 448).
S.D. Cavalieri, F.M.L. Silva, E.D. Velini, A.R. São José, S.M. Ulloa, A. Datta, J.D. Cavalieri, S.Z Knezevic   +7 more
doaj   +1 more source

ABIOTIC DEGRADATION OF IODOSULFURON-METHYL-ESTER IN AQUEOUS SOLUTION [PDF]

, 2005
The abiotic degradation of iodosulfuron-methyl-ester was investigated under both alkaline and acidic pH conditions in the dark, and results showed it to be a rather stable molecule in neutral or slightly alkaline environments.
C. EMMELIN, J. M. CHOVELON, M. BRIGANTE, PREVITERA, LUCIO, R. BAUDOT   +4 more
core   +1 more source

Meta‐analysis of sotagliflozin, a dual sodium‐glucose‐cotransporter 1/2 inhibitor, for heart failure in type 2 diabetes

ESC Heart Failure, Volume 12, Issue 2, Page 968-979, April 2025.
Abstract Sodium‐glucose co‐transporters (SGLTs) mediate sodium and glucose transport across cell membranes. SGLT2 inhibitors have a recognized place within heart failure (HF) guidelines. We evaluated the effect of sotagliflozin on HF and cardiovascular outcomes in participants with type 2 diabetes. Scopus, Medline, Embase and Central were searched from
Maria Anna Bantounou, Panagiotis Sardellis, Josip Plascevic, Ribeya Awaes‐Mahmood, Justyna Kaczmarek, Daniel Black Boada, Rosa Thuemmler, Sam Philip   +7 more
wiley   +1 more source

Response of maize (Zea mays L.) to rimsulfuron under salt conditions

Acta Societatis Botanicorum Poloniae, 2011
Investigations were carried out to determine the possible interaction between salinity (60 mmol*dm-3 NaCl) and phytotoxicity of herbicide Titus 25 DF (sulfonylurea herbicide containing active ingredient rimsulfuron).
Elżbieta Sacała, Anna Demczuk, Tomasz Michalski   +2 more
doaj   +1 more source

Treatment Dynamics in People Who Initiate Metformin or Sulfonylureas for Type 2 Diabetes: A National Cohort Study

Frontiers in Pharmacology, 2021
Aim: To investigate the incidence of, and factors associated with addition and switching of glucose-lowering medications within 12-months of initiating metformin or a sulfonylurea for type 2 diabetes (T2D).Methods: We identified 109,573 individuals aged ...
Stephen Wood, Dianna J. Magliano, Dianna J. Magliano, J Simon Bell, J Simon Bell, Jonathan E. Shaw, Jenni Ilomäki, Jenni Ilomäki   +7 more
doaj   +1 more source

Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006-2013. [PDF]

, 2016
ObjectiveTo examine temporal trends in utilization of glucose-lowering medications, glycemic control, and rate of severe hypoglycemia among patients with type 2 diabetes (T2DM).Research design and methodsUsing claims data from 1.66 million privately ...
Gill, Thomas M, Herrin, Jeph, Inzucchi, Silvio E, Krumholz, Harlan M, Lipska, Kasia J, McCoy, Rozalina G, Ross, Joseph S, Shah, Nilay D, Steinman, Michael A, Yao, Xiaoxi   +9 more
core   +1 more source

Sodium‐glucose cotransporter 2 inhibitors and the risk of late onset epilepsy: A real‐world cohort study

Epilepsia, EarlyView.
Abstract Objective Late onset epilepsy (LOE) is associated with substantial morbidity. Sodium‐glucose cotransporter 2 inhibitors (SGLT2i) may exert neuroprotective effects. This study evaluated the association between SGLT2i and risk of LOE among older adults with type 2 diabetes mellitus.
Bing‐Hua Lin, Hui‐Min Huang, Hui‐An Lin, Sheng‐Feng Lin   +3 more
wiley   +1 more source